Shiferman Gregory L. sold SAGE
February 13, 2025 · Form 4 insider transaction
Shiferman Gregory L. sold 376 shares of SAGE Therapeutics Holdings at $7.18 per share, a transaction worth $2.7K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
376
Price
$7.18
Total value
$2.7K
InsiderShiferman Gregory L.
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 13, 2025
Filing dateFebruary 14, 2025
Shares owned after33,512
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On February 13, 2025, the reporting person vested 1,125 shares of time-based restricted stock units (RSUs) granted on February 13, 2023 under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. This grant vests 25% on each grant anniversary date over four years. Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.